Catalyst Event
Merck and Co Inc (MRK) · Other
From KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index (KUSDV100P)
3/18/2026, 12:00:00 AM
Merck's Animal Health unit received FDA approval on March 18, 2026, for an expanded label for Bravecto Quantum, a once-yearly injectable parasiticide for dogs, to treat and control Asian longhorned and Gulf Coast ticks.
Korean Translation
머크의 동물 의약품 사업부가 2026년 3월 18일, 1년 1회 주사하는 반려견용 구충제 브라벡토 퀀텀(Bravecto Quantum)에 대해 아시아 긴뿔 진드기 및 걸프 코스트 진드기 치료 및 제어를 포함하도록 확대된 라벨을 FDA로부터 승인받음.
Related Recent Events
Devon Energy Corp (DVN) · Earnings Release
Market reaction is estimated to be significant as the first report post-merger; Q1 2026 earnings release is scheduled.
5/5/2026, 12:00:00 AM
Conocophillips (COP) · Earnings Release
First-quarter 2026 financial and operating results are scheduled to be released before the market opens on April 30, 2026. Medium importance estimated as earnings reports typically drive significant price movement, scheduled.
4/30/2026, 12:00:00 AM
Halliburton Co (HAL) · Earnings Release
First quarter 2026 earnings release and conference call scheduled. This scheduling announcement is estimated to have a price impact of 1% or more, scheduled.
4/28/2026, 12:00:00 AM
Chevron Corp (CVX) · Earnings Release
Chevron is scheduled to report its Q1 2026 earnings on April 24, 2026; analysts forecast an EPS of $1.72, scheduled.
4/24/2026, 12:00:00 AM
Comcast Corp (CMCSA) · Earnings Release
First quarter 2026 earnings release and conference call on April 23, 2026, with importance estimated as Low as it is a routine earnings announcement, scheduled.
4/23/2026, 12:00:00 AM
CME Group Inc (CME) · Earnings Release
CME Group is scheduled to announce its earnings for the first quarter of 2026 before the market opens on April 22, 2026; low importance is estimated as the announcement is expected to cause at least a 1% price impact, scheduled.
4/22/2026, 12:00:00 AM